Mannitol Patent Expiration
Mannitol is Used for assessing bronchial hyperresponsiveness in patients over 6 years old without clinically apparent asthma. It was first introduced by B Braun Medical Inc
Mannitol Patents
Given below is the list of patents protecting Mannitol, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Aridol Kit | US5817028 | Method and device for the provocation of air passage narrowing and/or the induction of sputum |
Feb 23, 2015
(Expired) | Pharmaxis Europe |
Mannitol's Family Patents
Explore Our Curated Drug Screens
Clinical Trials
Recent Clinical Trials on Mannitol:
Sometimes companies keep conducting clinical trials even after the drug's approval to discover new formulations, methods of use, or new treatment indications, so they could file for additional patents or receive regulatory exclusivity extensions, such as pediatric exclusivity, potentially delaying generic competition. Based on these recent clinical trials, generic companies need to consider the potential for new intellectual property or regulatory hurdles. These strategic moves by the drug owner might delay generic substitution or lead to additional sales of the brand drug, even after patent expiry.
